Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) have been assigned a consensus recommendation of “Buy” from the twelve brokerages that are currently covering the firm. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $42.00.
ZLTQ has been the subject of a number of recent research reports. Stifel Nicolaus raised their target price on Zeltiq Aesthetics from $38.00 to $52.00 and gave the stock a “buy” rating in a research report on Wednesday, September 21st. Leerink Swann reissued a “buy” rating on shares of Zeltiq Aesthetics in a research report on Thursday, June 30th. Brean Capital reissued a “buy” rating and issued a $35.00 target price on shares of Zeltiq Aesthetics in a research report on Tuesday, June 21st. Maxim Group raised their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the stock a “buy” rating in a research report on Tuesday, August 9th. Finally, Zacks Investment Research raised Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a research report on Saturday, July 23rd.
In related news, Director Andrew N. Schiff sold 500,000 shares of Zeltiq Aesthetics stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $36.39, for a total transaction of $18,195,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Keith J. Sullivan sold 8,000 shares of Zeltiq Aesthetics stock in a transaction on Monday, July 11th. The shares were sold at an average price of $30.02, for a total value of $240,160.00. Following the sale, the insider now directly owns 77,922 shares of the company’s stock, valued at approximately $2,339,218.44. The disclosure for this sale can be found here. Corporate insiders own 15.60% of the company’s stock.
Large investors have recently bought and sold shares of the stock. PineBridge Investments L.P. raised its stake in Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock valued at $112,000 after buying an additional 193 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of Zeltiq Aesthetics by 26.9% in the second quarter. Teacher Retirement System of Texas now owns 4,884 shares of the company’s stock valued at $133,000 after buying an additional 1,036 shares during the period. Legal & General Group Plc raised its stake in shares of Zeltiq Aesthetics by 1.7% in the first quarter. Legal & General Group Plc now owns 4,963 shares of the company’s stock valued at $134,000 after buying an additional 83 shares during the period. Mason Street Advisors LLC purchased a new stake in shares of Zeltiq Aesthetics during the second quarter valued at about $173,000. Finally, Calamos Wealth Management LLC purchased a new stake in shares of Zeltiq Aesthetics during the second quarter valued at about $200,000.
Shares of Zeltiq Aesthetics (NASDAQ:ZLTQ) opened at 40.22 on Thursday. The company has a market capitalization of $1.59 billion, a P/E ratio of 60.48 and a beta of 0.79. Zeltiq Aesthetics has a 12 month low of $18.41 and a 12 month high of $41.43. The company’s 50 day moving average price is $38.74 and its 200 day moving average price is $31.88.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings results on Monday, August 8th. The company reported ($0.12) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by $0.07. The business had revenue of $89.50 million for the quarter, compared to analysts’ expectations of $79.68 million. Zeltiq Aesthetics had a net margin of 9.54% and a negative return on equity of 9.90%. The business’s revenue was up 38.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.03 earnings per share. Analysts expect that Zeltiq Aesthetics will post ($0.13) EPS for the current fiscal year.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.